US Patent 10647701 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
Patent 10647701 was granted and assigned to Novartis on May, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 5, 2019
Date of Patent
May 12, 2020
Patent Applicant
Patent Application Number
16532118
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10647701 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
